Variations of prothrombin time and international normalized ratio in patients treated with warfarin

被引:10
作者
Ho, CH [1 ]
Lin, MW
You, JY
Chen, CC
Yu, TJ
机构
[1] Vet Gen Hosp, Dept Med, Div Hematol, Taipei, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
[3] Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan
[4] Vet Gen Hosp, Div Cardiovasc Surg, Dept Surg, Taipei, Taiwan
关键词
anticoagulant therapy; different time periods; international normalized ratio; prothrombin time;
D O I
10.1016/S0049-3848(02)00339-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prothrombin time is a standard screening test to monitor patients treated with oral anticoagulants. We hypothesize that INR measurements will not vary a lot within a given day in a given patient. The present study was thus conducted to compare the change of the international normalized ratio (INR) of prothrombin time (PT) within I day in patients treated with warfarin. Thirty such patients and nineteen healthy controls were enrolled into this study. PT was performed in four time points or a day in all subjects, two in the morning and two in the afternoon. The four INR values obtained were compared with each other to find little change in the series of time either in patients or in healthy controls. Neither were they affected by renal function, liver function, sex, age, hemoglobin, white cell count, platelet. treatment duration of warfarin, or alcoholic drinking. INR could be measured in any time of a day to have values equally valuable in clinical use. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:277 / 280
页数:4
相关论文
共 12 条
[1]  
BLESKE BE, 1995, PHARMACOTHERAPY, V15, P709
[2]  
CHAN CW, 1980, CLIN ORTHOP RELAT R, P253
[3]   POSTOPERATIVE DEEP-VEIN THROMBOSIS IN THE TAIWANESE CHINESE POPULATION [J].
CHENG, KK ;
LAI, ST ;
YU, TJ ;
KUO, SM .
AMERICAN JOURNAL OF SURGERY, 1987, 153 (03) :302-305
[4]  
HILLMAN RS, 1995, HEMATOLOGY CLIN PRAC, P498
[5]   Prevalence of prothrombin 20210A allele and methylenetetrahydrofolate reductase C677T genetic mutations in the Chinese population [J].
Ho, CH .
ANNALS OF HEMATOLOGY, 2000, 79 (05) :239-242
[6]   Prevalence of activated protein C resistance in the Chinese population [J].
Ho, CH .
THROMBOSIS RESEARCH, 1997, 88 (05) :409-412
[7]  
HO CH, 1999, CHUNG HUA I HSUEH TS, V62, P875
[8]   DRUG-INTERACTIONS WITH WARFARIN [J].
SERLIN, MJ ;
BRECKENRIDGE, AM .
DRUGS, 1983, 25 (06) :610-620
[9]   TEMPORAL VARIATION IN THE EFFECTS OF WARFARIN ON THE VITAMIN-K CYCLE [J].
SOULBAN, G ;
LABRECQUE, G ;
BELANGER, PM .
CHRONOBIOLOGY INTERNATIONAL, 1990, 7 (5-6) :403-411
[10]  
SOULBAN G, 1988, ANN REV CHRONOPHARMA, V5, P465